Total Days in Country
Total Days in Hospital
Treatment cost starts from
CAR T-Cell Therapy in India is transforming cancer care with its targeted, personalized approach. India has emerged as a prominent destination for advanced cancer treatments, including CAR T-cell therapy, due to its highly skilled specialists and cost-effective options. Tripoheal, based in New Delhi, connects international patients with leading hospitals and oncologists, making access to this innovative therapy more achievable and convenient.
CAR T-Cell Therapy, or Chimeric Antigen Receptor T-Cell Therapy, is a breakthrough in immunotherapy where a patient’s T-cells (a type of immune cell) are genetically engineered to better recognize and fight cancer cells. This therapy is particularly effective for certain types of blood cancers, such as:
Acute Lymphoblastic Leukemia (ALL)
Non-Hodgkin’s Lymphoma (NHL)
Chronic Lymphocytic Leukemia (CLL)
Multiple Myeloma
In CAR T-cell therapy, T-cells are extracted, modified in a lab to express CAR proteins that can specifically target cancer cells, and then reintroduced into the patient’s bloodstream. These CAR T-cells work as a customized defense system, seeking and destroying cancer cells with precision.
Why Choose India
for CAR T-Cell Therapy?
India has
become a preferred destination for CAR T-Cell Therapy due to its advanced
oncology centers, experienced oncologists, and competitive treatment costs.
Some of the reasons to choose India include:
State-of-the-Art
Facilities – India’s top cancer hospitals are equipped with cutting-edge
technology, including CAR T-cell manufacturing units and specialized labs.
Affordable
Care – CAR T-cell therapy costs in India are significantly lower compared to
the US or Europe, making it an accessible option for patients worldwide.
Expert
Oncologists – India’s medical teams are highly trained in immunotherapy and
personalized treatments, ensuring quality care and successful outcomes.
Tripoheal
streamlines the journey for international patients seeking CAR T-cell therapy
in India. We offer end-to-end assistance, including pre-treatment
consultations, hospital appointments, travel arrangements, and personalized
support throughout the process. Tripoheal’s network includes India’s leading
cancer hospitals and oncology experts, ensuring that patients receive the best
possible care.
Contact Us
For more
information on CAR T-cell therapy in India and how Tripoheal can assist you,
contact us today. Let us help you access advanced cancer treatment with quality
care in India.
W-3, Ashok Marg, near Radisson Blu Hotel, Sector-1, Vaishali, Ghaziabad, Uttar Pradesh 201012
Total capacity of
350 beds
B-22, Sector 62, Gautam Buddh Nagar, Noida, Uttar Pradesh , Noida, UP, India, 201301
Total capacity of
200 beds
1,2 Press Enclave Road, Saket , New Delhi, India, 110017
Total capacity of
430 beds
Pusa Road, Radha Soami Satsang,, Rajendra Nagar , New Delhi, India
Total capacity of
650 beds
Sector 16 Rd, Nirman Kunj, ADB PWD Colony, Sector 16A, Faridabad, Haryana 121002
Total capacity of
400 beds
21 Greams Lane, off Greams Road, Apollo Hospitals, Chennai-600006, Tamil Nadu, India.
Total capacity of
695 beds
Lorem ipsum dolor sit amet consectetur adipisicing elit. Eligendi veniam sunt facilis est perferendis quia?
Disclaimer: Tripoheal does not provide medical diagnoses or treatments. We facilitate communication with the medical professionals selected by the client and, based on the information provided by the client, present options shared by those medical professionals. While we strive to convey information accurately and clearly, the client is ultimately responsible for fully understanding all options before making any decisions.
